Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.UK to get GBP1 billion biotech funding by 2008
The new funding allocations include stem cell research and DNA-based medicines and will provide a huge boost to British science, which is already world class. The allocations come
The new funding allocations include stem cell research and DNA-based medicines and will provide a huge boost to British science, which is already world class. The allocations come
The results of a safety analysis, which was performed as a secondary endpoint, suggest that Seroquel (quetiapine fumarate) did not increase the risk of cerebrovascular adverse events (CVAEs)
The Respiratory Disease Network (RDN) is a group of three compounding pharmacies established by SourceCF in September 2004. The litigation concerned the marketing of a compounded formulation of
Griseofulvin oral suspension, USP 125mg/5mL, acts systemically to inhibit the growth of trichophyton, mMicrosporum, and epidermophyton genera of fungi. Major indications for the product are tinea capitis (ringworm
In a response to ongoing concerns about manufacturing quality, the FDA and the Department of Justice seized supplies of the antidepressant Paxil CR and diabetes drug Avandamet. Manufacturing
Neuren Pharmaceuticals and Metabolic Pharmaceuticals will jointly develop Neuren’s class of neuro-regenerative peptides (NRPs) with all intellectual property and commercial outcomes to be equally shared. Furthermore, the two
The approval makes Clarinex-D 24-hour (desloratadine 5mg and pseudoephedrine sulfate USP 240mg) extended release tablets available in time for the spring allergy season. Clarinex-D 24-hour will be the
The results show that the vaccination protocol successfully generated telomerase-specific T-cell responses in 19 of 20 subjects. The vaccine was well tolerated with no major treatment-related toxicities, and
On March 1, the UK government indicated its intention to purchase 14.6 million units of oseltamivir (Roche’s Tamiflu) over two years as part of the UK’s preparedness for
The AmpliMed study will determine the maximum tolerated doses of Amplimexon (imexon injection) as well as its toxicity in combination with gemcitabine (marketed by Eli Lilly as Gemzar)